|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 487/04 | |
| A61K 31/4184 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2727921 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14153258.0 |
| Europos patento paraiškos padavimo data | 2008-10-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-05-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-04-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 979654 P | 2007-10-12 | US |
| (72) |
Zhu, Guidong, US
|
| (73) |
AbbVie Ireland Unlimited Company,
70 Sir John Rogerson`s Quay, Dublin 2,
IE
|
| (54) | 2-((R)-2-methylpyrrolidin-2-YL)-1H-benzimidazole-4-carboxamide crystalline form 2 |
| 2-((R)-2-methylpyrrolidin-2-YL)-1H-benzimidazole-4-carboxamide crystalline form 2 |